Ikena Oncology, Inc. (IKNA) DCF Valuation

Ikena Oncology, Inc. (IKNA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Ikena Oncology, Inc. (IKNA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (IKNA) DCF Calculator enables you to evaluate Ikena Oncology, Inc. valuation using real-world financial data, offering complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 13.8 9.2 31.0 15.6 9.2 8.6 8.1 7.6 7.1 6.7
Revenue Growth, % 0 -33.15 237.01 -49.59 -41.35 -6.02 -6.02 -6.02 -6.02 -6.02
EBITDA -18.2 -44.2 -33.6 -70.2 -74.4 -8.6 -8.1 -7.6 -7.1 -6.7
EBITDA, % -132.69 -480.95 -108.42 -449.18 -812.19 -100 -100 -100 -100 -100
Depreciation .1 1.3 1.7 2.0 1.0 .8 .7 .7 .6 .6
Depreciation, % 0.88708 13.75 5.54 13.02 11.14 8.87 8.87 8.87 8.87 8.87
EBIT -18.4 -45.5 -35.3 -72.2 -75.4 -8.6 -8.1 -7.6 -7.1 -6.7
EBIT, % -133.58 -494.7 -113.96 -462.2 -823.33 -100 -100 -100 -100 -100
Total Cash 82.1 162.5 232.2 156.9 175.5 8.6 8.1 7.6 7.1 6.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0 0 0 0 0
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 0 0 0 0 0 0 0 0
Accounts Payable .9 2.1 2.4 2.1 2.1 1.3 1.2 1.1 1.1 1.0
Accounts Payable, % 6.8 23.08 7.69 13.4 22.55 14.71 14.71 14.71 14.71 14.71
Capital Expenditure -.3 -.8 -1.8 -1.4 -.4 -.5 -.5 -.5 -.4 -.4
Capital Expenditure, % -2.3 -8.33 -5.68 -9.16 -4.52 -6 -6 -6 -6 -6
Tax Rate, % 0.23709 0.23709 0.23709 0.23709 0.23709 0.23709 0.23709 0.23709 0.23709 0.23709
EBITAT -18.4 -45.5 -35.3 -69.9 -75.2 -8.6 -8.0 -7.6 -7.1 -6.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -17.6 -43.8 -35.1 -69.6 -74.7 -9.1 -7.9 -7.4 -7.0 -6.5
WACC, % 6.41 6.41 6.41 6.39 6.41 6.41 6.41 6.41 6.41 6.41
PV UFCF
SUM PV UFCF -31.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -7
Terminal Value -151
Present Terminal Value -111
Enterprise Value -143
Net Debt -109
Equity Value -34
Diluted Shares Outstanding, MM 42
Equity Value Per Share -0.81

What You Will Get

  • Comprehensive IKNA Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Ikena Oncology’s future performance.
  • User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Ikena Financials: Gain access to precise pre-loaded historical data and future forecasts.
  • Adjustable Forecast Parameters: Modify highlighted cells for metrics such as WACC, growth rates, and profit margins.
  • Real-time Calculations: Automatic adjustments for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to illustrate your valuation findings.
  • Designed for All Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the comprehensive Excel file featuring Ikena Oncology, Inc. (IKNA) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and compare results instantly.
  • Make Decisions: Utilize the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Ikena Oncology, Inc. (IKNA)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters effortlessly to suit your analytical needs.
  • Real-Time Valuation: Instantly observe changes to Ikena's valuation as you modify the inputs.
  • Preloaded Data: Comes with Ikena's actual financial metrics for immediate analysis.
  • Endorsed by Experts: Widely utilized by investors and analysts for sound decision-making.

Who Should Use Ikena Oncology, Inc. (IKNA)?

  • Investors: Make informed decisions in the biotech sector with our cutting-edge insights.
  • Healthcare Analysts: Streamline your research with comprehensive data on oncology innovations.
  • Consultants: Easily modify our resources for client discussions or strategic reports.
  • Biotech Enthusiasts: Enhance your knowledge of cancer therapies through detailed case studies.
  • Educators and Students: Utilize our materials as a hands-on resource in life sciences education.

What the Template Contains

  • Pre-Filled Data: Includes Ikena Oncology's historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Ikena Oncology’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.